Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice
Open Access
- 1 April 2009
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 119 (4), 813-825
- https://doi.org/10.1172/jci36809
Abstract
Regulation of the formation and function of bone-resorbing osteoclasts (OCs) is a key to understanding the pathogenesis of skeletal disorders. Gene-targeting studies have shown that the RANK signaling pathway plays a critical role in OC differentiation and function. Although pharmaceutical blockade of RANK may be a viable strategy for preventing bone destruction, RANK is implicated in multiple biological processes. Recently, a cytoplasmic motif of RANK was identified that may be specifically involved in OC differentiation. Here, we developed a cell-permeable inhibitor termed the RANK receptor inhibitor (RRI), which targets this motif. The RRI peptide blocked RANKL-induced OC formation from murine bone marrow–derived macrophages. Furthermore, RRI inhibited the resorptive function of OCs and induced OC apoptosis. Treatment with the peptide impaired downstream signaling of RANK linked to Vav3, Rac1, and Cdc42 and resulted in disruptions of the actin cytoskeleton in differentiated OCs. In addition, RRI blocked inflammation-induced bone destruction and protected against ovariectomy-induced bone loss in mice. These data may be useful in the development of selective therapeutic agents for the treatment of osteoporosis and other bone diseases.This publication has 58 references indexed in Scilit:
- CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclastsProceedings of the National Academy of Sciences of the United States of America, 2007
- Pathological role of osteoclast costimulation in arthritis-induced bone lossProceedings of the National Academy of Sciences of the United States of America, 2007
- Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systemsNature Reviews Immunology, 2007
- Biology of RANK, RANKL, and osteoprotegerinArthritis Research & Therapy, 2007
- A TNF receptor loop peptide mimic blocks RANK ligand–induced signaling, bone resorption, and bone lossJCI Insight, 2006
- NFATc1 regulation of the human β3 integrin promoter in osteoclast differentiationGene, 2006
- Intranasal delivery of the cytoplasmic domain of CTLA-4 using a novel protein transduction domain prevents allergic inflammationNature Medicine, 2006
- Osteoclast differentiation and activationNature, 2003
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Rac-GTPase, osteoclast cytoskeleton and bone resorptionEuropean Journal of Cell Biology, 1999